A Clinician’s Crash Course in Ninaveli Regenerative Aesthetics
The global medical aesthetics market is experiencing a profound paradigm shift. While traditional dermal fillers remain a clinical staple for volume replacement, modern practitioners are increasingly leaning towards cellular regeneration and biostimulation. Developed by Novaleen Bio and manufactured in South Korea under strict GMP, ISO-13485 and ISO-22716 regulations, the Ninaveli product portfolio represents the vanguard of this regenerative revolution.
For clinics looking to scale their treatment menus with scientifically backed, safe, and highly pure injectables, this comprehensive guide breaks down the core technologies within the Ninaveli aesthetic ecosystem.
Core Product Classifications
1. Advanced Polynucleotides (PN) and PDRN Solutions
Polynucleotides (PN) are the bedrock of modern cellular repair, acting as true biostimulators that trigger the skin’s natural healing cascades rather than simply masking signs of ageing. Derived from highly purified salmon DNA, Ninaveli’s PN range is meticulously processed to exhibit exceptionally low protien and endotoxin levels, to ensure maximum clinical purity.
Ninaveli PN 2.5% (with Lidocaine)
A highly purified 2.5% Polynucleotide (PN) formula containing 25mg/ml of active substance paired with 0.3% Lidocaine. Supplied in a generous 2.5ml syringe, this export-ready configuration provides intensive deep-tissue structural support and triggers rapid fibroblast activation.
Ninaveli PN 2%
A highly purified, standard-setting 2% Polynucleotide (PN) formula containing 20mg/ml of active regenerative molecules. Supplied in a 2.5ml syringe, it is designed for global tissue regeneration, wrinkle reduction, and dermal repair.
Ninaveli PN Pro
A specialized 2% Polynucleotide (PN) formula delivering 20mg/ml of active nucleotide molecules in a 2ml syringe configuration. This line is officially KFDA-approved, providing clinicians with verified evidence of regulatory safety and efficacy.
Ninaveli PN 2% Face
An advanced regenerative formula packed into a 5ml sterile vial, featuring a market-leading 2% concentration of pure Polynucleotides. Explicitly CPNP and SCPN registered, it is optimised for wide-area mesotherapy to revitalize and reinforce intensive dermal structures.
2. Targeted Skin Boosters and Hybrid Matrices
When single-molecule treatments are insufficient, Ninaveli leverages synergistic blending of distinct molecular weights and active ingredients to correct skin hydration and structural laxity simultaneously.
Ninaveli PN + HA
A balanced, high-performance skin booster combining 10mg/ml Polynucleotides (PN) with 10mg/ml Hyaluronic Acid (HA) to establish a 1% PN + 1% HA therapeutic matrix. Supplied in a 2.5ml syringe, it quenches severe skin dehydration while repairing cellular damage.
Ninaveli HI-LO
An ultra-pure, high-concentration hybrid booster balancing 70mg of high molecular weight Hyaluronic Acid (H-HA) with 10mg of low molecular weight Hyaluronic Acid (L-HA), and 0.5% pure Polynucleotides in a 2.5ml syringe. It remodels the extracellular matrix by triggering long-term bio-remodeling.
Ninaveli H-L 40
A dual-weight skin booster featuring an evenly distributed ratio of 40mg High-HA and 40mg Low-HA. This formulation provides a smooth, monophasic spreading profile for deep hydration across the facial canvas.
Ninaveli Face Glow
A multi-targeted complex delivered in a 5ml sterile vial. CPNP and SCPN registered, it features a potent blend of 1% Polynucleotides (PN), 1% Hyaluronic Acid (HA), and Glutathione to brighten the skin tone, eliminate surface dehydration, and reduce fine expression lines.
3. Advanced Collagen Biostimulators
To deliver long-lasting tissue regeneration and natural volumization, Ninaveli’s biostimulatory lines activate endogenous collagen cascades rather than relying on temporary external volume.
Ninaveli CaHA
A premium Calcium Hydroxylapatite collagen bio-stimulating filler delivered in a 1ml syringe. It yields immediate structural enhancement by correcting deep wrinkles and restoring facial volume, followed by long-term tissue regeneration.
Ninaveli PLA 200
A powerful collagen-inducing injectable consisting of 200mg of Poly-D,L-Lactic Acid (PDLLA) paired with Carboxymethylcellulose (CMC). Delivered in a sterile vial, it creates a uniform, highly predictable biostimulatory response to correct deep facial folds and enhance facial appearance.
4. Lyophilized Cellular Complexes & Aftercare
Pushing the boundaries of aesthetic biotechnology, these advanced multi-vial systems protect volatile active ingredients via freeze-dried isolation until the moment of clinical application.
Ninaveli Exosomes (Exoleen)
A powerful, dual-vial regenerative system. Vial 1 contains 800mg of freeze-dried Ginseng Root Exosomes, Mannitol, and Trehalose. Vial 2 supplies 4ml of liquid activator rich in PN, HA, Proteoglycan, Peptides, and Tranexamic Acid to target cellular turnover and hyperpigmentation.
Ninaveli NAD+ NMN
A cellular-rejuvenation system pairing a freeze-dried powder vial containing 100mg of nicotinamide mononucleotide (NMN) and Nicotinamide Riboside (NR) with a second 4ml liquid vial composed of pure Hyaluronic Acid and essential Amino Acids, effectively rejuvenating facial skin.
Ninaveli Classic NAD+ NMN, PN, RN
An advanced anti-aging mesotherapy complex in a liquid only vial integrating NAD+ NMN, Nicotinamide Riboside (NR), and Polynucleotides (PN) to target mitochondrial health and reverse cellular senescence.
Ninaveli PDRN Pro Advanced Serum
A high-performance clinical aftercare formula presented in a 50ml pipette bottle. CPNP and SCPN certified, it packs a potent dose of 10,000ppm PDRN, 4% Panthenol, Hyaluronic Acid, Niacinamide, and Centella Asiatica (Cica) to accelerate healing and slash down post-procedure erythema.
5. Advanced Hyaluronic Acid Dermal Fillers
To complement its cellular repair range, the Ninaveli portfolio provides cross-linked Hyaluronic Acid dermal fillers utilizing advanced cross-linking technology to ensure smooth extrusion, high viscoelasticity, and predictable degradation profiles.
Ninaveli HA Fillers (KFDA Certified)
Premium quality, cross-linked, monophasic Hyaluronic Acid (HA) dermal fillers formulated at a concentration of 24mg/ml with 0.3% Lidocaine. Delivered in a 1.1ml syringe, this KFDA-certified line is engineered for export. It is available in three distinct models:
Fine: Tailored for superficial lines and delicate skin corrections.
Deep: Optimized for mid-to-deep dermal layers, nasolabial folds, and volume restoration.
Grand: Designed for deep subcutaneous or supraperiosteal placement to deliver maximum structural contours.
Ninaveli Classic HA Fillers
A dedicated export line of premium, cross-linked, monophasic Hyaluronic Acid dermal fillers formulated at 24mg/ml with 0.3% Lidocaine in a 1.1ml syringe. Engineered to ensure reliable, high-cohesivity performance, this core range is divided into three adaptable clinical weights: Fine, Deep, and Grand, with each clinical weight serving the same purpose as in the Ninaveli HA Fillers (KFDA Certified) lineup.
Ninaveli Kiss Lip Filler
A specialized dermal filler explicitly engineered specifically for perioral architecture and lip augmentation. This unique formula contains 26mg of a distinct dual-weight (High HA + Low HA) matrix and is infused with Vitamin B12, which gives the product its signature pink color and provides optimized tissue integration. It is supplied in a 1.1ml syringe and is our most in-demand dermal filler product.
The Takeaway for Practitioners
By maintaining end-to-end control over our advanced South Korean production pipeline and distributing globally through hubs in London, Seoul, and Dubai, Novaleen Bio eliminates supply chain friction to ensure absolute product consistency and maximum clinical purity. Our vertically integrated manufacturing model allows us to bypass third-party logistics margins, delivering top-tier regenerative solutions directly to your practice at highly competitive price points. Incorporating the cutting-edge Ninaveli range into your treatment menu guarantees clinical predictability, exceptional product stability, and the advanced patient outcomes that define the future of the beauty industry.
